GlassScriptPhysician profile
Jordan Robert Hill
NPI 1265813786
$3,460.33
in general payments reported to CMS, 2019-2025
25 companies · $712 in 2025
The $712 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $651 · 2020: $181 · 2021: $322 · 2022: $622 · 2023: $327 · 2024: $646 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,684.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $427.63 | 2019-2020 | |
| Biotissue Holdings INC. | $355.90 | 2020-2025 | |
| Abbvie INC. | $294.11 | 2022-2025 | |
| Alcon Vision LLC | $254.45 | 2019-2024 | Rocklatan |
| Dompe US, INC. | $253.55 | 2020-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $251.56 | 2020-2022 | |
| Glaukos Corporation | $247.56 | 2020-2025 | Photrexa Viscous and Photrexa, Ce-Marked Kxla System |
| Harrow Eye, LLC | $232.72 | 2023-2025 | Vevye, Iheezo |
| Rxsight INC | $171.01 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Tarsus Pharmaceuticals, INC. | $132.69 | 2024-2025 | Xdemvy |
| Genentech USA, INC. | $121.82 | 2023 | Vabysmo |
| Sight Sciences, INC. | $100.78 | 2019 | |
| Bausch & Lomb Americas INC. | $84.21 | 2022-2025 | Scoutpro Osmolarity System, Miebo, Xiidra |
| Oyster Point Pharma, INC. | $78.38 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $71.26 | 2021-2025 | Cequa |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $63.76 | 2020-2021 | |
| Thea Pharma INC. | $60.85 | 2023-2025 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $47.70 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $46.42 | 2019-2022 | |
| Genzyme Corporation | $41.35 | 2024 | |
| Mallinckrodt Hospital Products INC. | $32.93 | 2022 | |
| Kala Pharmaceuticals, INC. | $23.23 | 2021 | |
| New World Medical,INC. | $23.10 | 2024 | Kahook Dual Blade, Ahmed Glaucoma Valve, Clearpath |
| Aerie Pharmaceuticals, INC. | $22.06 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $21.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.